Skip to content
Back to announcement

20260402_MEDC_Laporan Informasi dan Fakta Material_32057287_lamp1.pdf

Other Text extracted MEDC

Source file signed link, expires in 15 minutes

This browser can't display the PDF inline. Open it in a new tab.

Extracted text 2

Page 1
PT Medco Energi Internasional Tbk             Tel +62-21 2995 3000
The Energy 53rd Fl., SCBD Area Lot 11 A       Fax +62-21 2995 3001
Jl. Jend. Sudirman, Jakarta 12190             www.medcoenergi.com
Indonesia




                            MedcoEnergi Announces Its Audited Full Year 2025 Results

                                      Summary Results
 Financial
     Net Income USD 101 million
     EBITDA USD 1,264 million
     Net Debt to EBITDA1 2.0x
     Cash and cash equivalents USD 633 million

Operational
   Oil & Gas production 156 mboepd
   Power generated sales 4,371 GWh
   Oil & Gas cash cost USD 8.6 per boe
   Capital expenditures USD 437 million


Jakarta, April 2nd, 2026 – PT Medco Energi Internasional Tbk2 announces its Full Year 2025 Audited
Financial Results.

Roberto Lorato, CEO, said: “In 2025 we delivered strong results for both the Company and our
shareholders. Our annual total shareholder return was a record 27%, returning USD 110 million to
shareholders as we met both our Oil & Gas production target of 156 mboepd and our Power sales target of
4,371 GWh.”

Financial Highlights
 Net income was USD 101 million compared to USD 367 million in 2024. The primary drivers for the
    drop were the lower contribution from AMMN, non-cash asset impairments, dry hole expenses at the
    Beluga PSC, and weaker commodity prices.
 EBITDA of USD 1,264 million was broadly in line with 2024, despite average realized oil prices
    declining by 15% from USD 78/bbl to USD 67/bbl year-on-year and gas prices softening from USD 7.0
    to USD 6.8 per mmbtu.
 Total Capex of USD 437 million and O&G cash costs of USD 8.6 per boe were in line with guidance.
 Consolidated debt grew to USD 3,646 million due to the purchase of the Marlin Natuna FPSO to ensure
    continued production from the Forel field in South Natuna Sea Block B, and project financing for
    renewable and gas IPP power developments.
 For Oil & Gas, net debt-to-EBITDA1 was 2.0x, compared with 1.8x in 2024, well within the Company’s
    targeted range.
 Liquidity remains strong with a robust cash position of USD 633 million at year-end, compared to
    USD 697 million in 2024.
 Dividends of USD 80 million were paid in 2025, approximately IDR 53.4 per share, a 19% increase
    from 2024.
 MSCI upgraded our ESG rating to ‘AAA’ and Moody’s upgraded our credit rating to Ba3.


1 Excluding PT Medco Power Indonesia (“MPI” or “Medco Power”)
2 PT Medco Energi Internasional Tbk (“MedcoEnergi” or “Company”)
Page 2
PT Medco Energi Internasional Tbk                            Tel +62-21 2995 3000
The Energy 53rd Fl., SCBD Area Lot 11 A                      Fax +62-21 2995 3001
Jl. Jend. Sudirman, Jakarta 12190                            www.medcoenergi.com
Indonesia




Operational Highlights
Oil & Gas
 Production in 2025 rose to 156 mboepd, driven by first production from the Terubuk and Forel fields in
    South Natuna Sea Block B, continued strong performance in Oman Block 60, and the increased
    operated ownership in the Corridor PSC. The Company exited the year with a run rate exceeding
    170 mboepd.
 Capex spend was USD 402 million, spent delivering a new production record in Oman Block 60,
    bringing onstream Terubuk and Forel fields in South Natuna Sea Block B, as well as the Corridor
    Suban-28 well and Suban Compressor Re-wheeling.
 We expanded our Sumatra position by increasing our Corridor working interest to 70%, and our
    effective interest in PT Transportasi Gas Indonesia to 40%, in addition we acquired a 45% operated
    interest in the Sakakemang PSC.
 On March 31st 2026 we signed the Cendramas PSC, re-entering Malaysia as the Operator of this
    offshore oil block. The Cendramas PSC is close to South Natuna Sea Block B operations and shares
    similar geology and technical characteristics.

Power
 Power sales were 4,371 GWh, with 25% derived from renewables.
 Capex was USD 35 million primarily spent commissioning the Ijen Geothermal plant brought on in the
   first quarter, the East Bali Solar PV in the second quarter and completing the Batam ELB expansion
   in the fourth quarter.

Amman Mineral Internasional
 The Company met its 2025 concentrate production guidance, producing 446,563 dry metric tonnes
  containing 208.9 Mlbs of copper and 102.8 koz of gold and further refining 176 Mlbs of copper cathode
  and 124.7 koz of gold.

                                            2026 Full Year Guidance
           Oil & Gas production 165-170 mboepd
           Power sales 4,550 GWh
           Oil & Gas cash costs below USD 10/boe
           Capital expenditures, Oil & Gas USD 415 million and Power USD 15 million


Hilmi Panigoro, President Director, said "I am very pleased with our 2025 performance. Looking ahead to
2026, we remain committed to deliver value to our stakeholders with both Oil & Gas production and Power
sales guidance setting new records for Medco.”

PT Medco Energi Internasional Tbk (“MedcoEnergi”) is a leading Southeast Asian energy and natural resources company listed on the Indonesia Stock Exchange
(MEDC-IDX). MedcoEnergi has three key business segments, Oil & Gas, Power and Copper & Gold Mining. MedcoEnergi explores for and produces oil and gas
primarily in Indonesia. The Group operates gas, PV, geothermal and hydro power plants in Indonesia through PT Medco Power Indonesia and has a non-
consolidated interest in PT Amman Mineral Internasional Tbk which operates a large copper and gold mine in Indonesia.

This document may contain projections, plans, strategies, policies and objectives of MedcoEnergi which should be treated as forward looking statements within
the meaning of applicable law. Forward looking statements, by their nature, involve risks and uncertainties that could cause actual results to differ materially
from those expressed or implied in these statements. The Company does not guarantee that any action taken in reliance on this document will bring specific
results.

                                                        For further information please call:
                             Corporate Secretary | Investor Relations | Tel: (62-21) 2995 3000, Fax: (62-21) 2995 3001
                              Email: corporate.secretary@medcoenergi.com | investor.relations@medcoenergi.com
                                                         Website: www.medcoenergi.com

File

File Open PDF
Source IDX
Size0.71 MB
Published2 Apr 2026
Pages2
Characters6,414
Text sourceEmbedded text layer
OCR confidence—

Names mentioned 6 people and organisations named in the text · linked when the evidence is strong

linked org Medco Energi Internasional Tbk p.1 ×14
linked person Roberto Lorato p.1
linked org PT Medco Power Indonesia p.1 ×3
linked person Hilmi Panigoro p.2
linked org Amman Mineral Internasional Tbk p.2 ×3
unresolved org Indonesia Stock Exchange p.2

Extraction attempts how the parser did, and what it refused

Nothing structured was extracted from this document — the attempts below say why.

No extraction attempted yet.

↑↓ select ↵ open ⇧↵ see every result